Search

Insulet Corp

Suletud

SektorTervishoid

135.91 0.53

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

135.58

Max

136.56

Põhinäitajad

By Trading Economics

Sissetulek

3.9M

95M

Müük

40M

802M

P/E

Sektori keskmine

26.366

55.725

Aktsiakasum

1.66

Kasumimarginaal

11.85

Töötajad

5,400

EBITDA

-22M

132M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+20.08% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

5. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-2B

9.7B

Eelmine avamishind

135.38

Eelmine sulgemishind

135.91

Uudiste sentiment

By Acuity

100%

0%

305 / 339 Pingereas Healthcare

Insulet Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. sept 2026, 23:05 UTC

Insulet Corp's shares rose in after-market trading, maintaining a cumulative return above 0.90% since Friday's close despite ongoing performance challenges.

24. sept 2026, 22:55 UTC

Insulet Corp is trading modestly lower in after-market hours, continuing a downward trend with losses in the last three sessions and below its 20-day moving average.

23. sept 2026, 19:16 UTC

Insulet Corp shares fell sharply, currently positioned well below its 20-day moving average and near the lower end of its one-month range.

22. sept 2026, 20:07 UTC

News

Insulet Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential wrongdoing, leading shares to trade modestly lower.

21. sept 2026, 19:46 UTC

Insulet Corp is slightly higher in a routine trading session, recovering from earlier lows while fluctuating around the midpoint of its one-month range.

18. sept 2026, 19:36 UTC

Insulet Corp is trading slightly higher, showing little change since Thursday's close, and remains below its 20-day moving average.

17. sept 2026, 19:36 UTC

Insulet Corp shares are modestly higher, recovering from an earlier dip, though still below the 20-day moving average.

16. sept 2026, 22:56 UTC

Insulet Corp's shares rose in after-market trading, recovering from earlier losses and reaching their highest point of the day, despite remaining below their 20-day moving average.

15. sept 2026, 19:56 UTC

Insulet Corp's shares are higher during Tuesday's session, reflecting a directional gain since Monday's close. The stock remains below its 20-day moving average.

14. sept 2026, 21:41 UTC

Insulet Corp's shares are lower in after-market hours amid broader market declines, particularly in the tech sector, with no specific news driving the movement.

10. sept 2026, 20:07 UTC

News

Insulet Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing, contributing to a decline in shares during Thursday's session.

9. sept 2026, 23:16 UTC

Insulet Corp shares are higher in after-market hours, gaining since Wednesday's close. This follows a recent trend of four consecutive lower finishes.

8. sept 2026, 20:07 UTC

News
Social Media

Insulet Corp shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, targeting potential claims of corporate wrongdoing.

4. sept 2026, 20:07 UTC

Insulet Corp's shares are lower today, reaching a session low earlier. The stock remains above its 20-day moving average amid notable volatility.

3. sept 2026, 22:46 UTC

Insulet Corp shares are lower in after-market hours, despite earlier gains. No specific news was identified to explain the price movement.

2. sept 2026, 19:36 UTC

Insulet Corp shares are declining today, despite an earlier peak. Broader market concerns include heightened geopolitical tensions and potential supply disruptions.

1. sept 2026, 23:36 UTC

Insulet Corp's shares are higher in after-market hours, following notable trading activity. The stock remains above its 20-day moving average despite negative market sentiment.

31. aug 2026, 20:07 UTC

News

Insulet Corp reported 23.5% revenue growth for Q2 2026, though it lowered FY2026 guidance. Shares are gaining today amid broader market trends.

28. aug 2026, 19:16 UTC

Insulet Corp's shares are higher today, reflecting positive market sentiment despite earlier intraday volatility. No specific news was identified to explain the movement.

27. aug 2026, 19:26 UTC

News

Insulet Corp faces a class action lawsuit alleging securities fraud related to manufacturing defects, contributing to a decline in shares today.

26. aug 2026, 19:16 UTC

Social Media

Insulet Corp shares are higher today, supported by over $226,000 in December $200 call options. Recent PCE data may also influence market sentiment.

25. aug 2026, 23:16 UTC

News

Insulet Corp shares lower in after-market hours amid a class action lawsuit alleging false statements about manufacturing controls and safety compliance.

24. aug 2026, 19:56 UTC

News

Insulet Corp shares are lower amid negative sentiment from two class action lawsuits alleging securities fraud related to product safety concerns.

21. aug 2026, 19:56 UTC

Insulet Corp shares are higher today, reflecting positive market momentum. Broader market gains, particularly in cryptocurrency, contribute to the stock's upward movement.

20. aug 2026, 23:11 UTC

Insulet Corp shares are trading lower in after-market hours, continuing a decline that follows a reversal from earlier highs. No specific news was identified.

19. aug 2026, 23:01 UTC

Insulet Corp shares are higher in after-market trading, continuing a trend of gains over the last three sessions without any specific news driving the movement.

18. aug 2026, 20:03 UTC

Insulet Corp's shares are higher today, having previously peaked before pulling back. The stock has advanced since Monday's close, despite no specific news.

17. aug 2026, 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

14. aug 2026, 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

13. aug 2026, 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

Võrdlus sarnastega

Hinnamuutus

Insulet Corp Prognoos

Hinnasiht

By TipRanks

20.08% tõus

12 kuu keskmine prognoos

Keskmine 163.467 USD  20.08%

Kõrge 185 USD

Madal 144 USD

Põhineb 18 Wall Streeti analüütiku instrumendi Insulet Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

18 ratings

9

Osta

9

Hoia

0

Müü

Sentiment

By Acuity

305 / 339 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.